|
|
|
|
|
by brightsize
4381 days ago
|
|
A data point from the USA: I take a very low dose of lamotrigene extended-release (mild epilepsy). The brand-name cost of this was $1200-$1400 per month. The recently available generic version of this costs nearly $400/mo. And this is, again, for a very low dose. For someone with a moderate or severe seizure (or bipolor - it's used for that too) disorder, the cost might be 4-5x this. While one might argue that the name-brand version costs so much because of high R&D costs (dubious in my opinion), it's difficult to make that argument for the generic. It's expensive because the manufacturer can get away with it -- it's very much needed by the patients but the market is sufficiently limited in size that few potential competitors choose to target it. Generics can be inexpensive if the drug in question has a very large market - statins for example. But if not, and you don't work for a company that provides health insurance with prescription drug coverage, a drug you need may well be a drug that you cannot get because of its cost. |
|